Schedule 13G ownership disclosure

CHINA SXT PHARMACEUTICALS IN

Common stock, $0.08 par value · CUSIP: G2161P140

Event date: 2025-01-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Streeterville Capital LLC

    Shares: 0.00 · Class: 0.0%

  • Streeterville Management LLC

    Shares: 0.00 · Class: 0.0%

  • John M Fife

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001851416-25-000004
Form type
SCHEDULE 13G/A
Filer
China SXT Pharmaceuticals, Inc.
CIK
CIK 1723980
Filed
Jan 21, 2025
Reporting period
Jan 17, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub